The advanced therapy sector has experienced exponential growth in recent years related to the number of technologies and vendors entering the medical data devices market. A need for more specific, higher capability devices across multiple geographies has emerged for many clinical trials operations, owing in part to the increased uniqueness of the drugs and therapies undergoing development. In this white paper written by IQVIA Connected Devices leader Mike Bruhns, learn why it is important to not only find the device that meets the needs of your clinical trial, but also how to ask the right questions when choosing the appropriate device, and how to manage the complex logistical and regulatory challenges.